Background:The aim of this study was to evaluate the efficacy and safety of ibuprofen-containing products in the treatment of mild to moderate pain. The rationale for this study was to determine the efficacy and safety of ibuprofen-containing products in the treatment of mild to moderate pain.
Methods:An open-label, noncomparative, single-blind, non-inferiority study, in 32 patients, was conducted. Patients received ibuprofen tablets (NSAIDs, 50 mg, 100 mg, 200 mg, 400 mg and 600 mg; ibuprofen/dietary-containing products, ibuprofen/non-dietary-containing products, 200 mg/200 mg) twice daily for 6 months. The primary efficacy endpoint was the pain score change from baseline to 6 months. Secondary endpoints were the reduction in pain and the change from baseline to 6 months.
Results:Twenty-nine patients (mean age: 62.8 years, female: 16) were enrolled, and 19 were randomized. The mean duration of NSAID treatment was 8.1 months (SD: 1.7) and mean baseline pain score was 5.3 (SD: 1.5). The treatment of mild to moderate pain was significantly better than placebo in both short-term (3 months) and long-term (8.1 and 5.2 months) pain relief.
Conclusion:Long-term ibuprofen treatment significantly reduced pain scores compared to placebo.
Patient InformationThe patient information sheet for this study was developed by the National Institutes of Health (NIH). This information is based on data from a previously published study, which was the largest study of non-steroidal anti-inflammatory drugs in the history of NSAIDs.
This study was approved by the Research Ethics Committee of the University of Basel, Switzerland (E: 9/01).
Study DesignThe study was a randomized, double-blind, parallel-group, controlled trial. The patients were assigned to receive either ibuprofen (n = 16) or diclofenac (n = 8) for 6 months. The study was conducted on 32 patients with moderate to severe pain who were enrolled in the short-term pain-management group. The patients in the ibuprofen group were significantly more likely to have a mild to moderate pain score <5 (26% vs 10%, p <0.001) at 6 months. These patients also reported a significantly greater percentage of patients with mild to moderate pain scores >5 (20% vs 4%, p <0.001) at 6 months.
Patient's InformationThe study was conducted on 32 patients with moderate to severe pain.
Main ResultsThe patients were randomized in two arms (n = 32) to ibuprofen (n = 16) or diclofenac (n = 8) for 6 months. Ibuprofen significantly improved pain scores in short-term (3 months) and long-term (8.1 and 5.2 months) pain relief compared with diclofenac.
SafetyThe safety of ibuprofen-containing products was evaluated using the NSAID symptom score. The pain scores were evaluated at week 0, week 2, week 4, and week 8 in both short-term and long-term pain relief. Ibuprofen significantly reduced the symptom score at 3 months (median 3.1; range, 0-16.3), compared with diclofenac.
The ibuprofen-containing products had a significantly greater proportion of patients who reported a lower score (median 31%; range, 15-48) compared with the diclofenac group.
Ibuprofen (NSAID)
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation, including headaches, muscle pain, toothache, menstrual cramps, dental pain, and fever. It is also used to reduce fever.
NSAIDs relieve pain by reducing the amount of chemicals in the body that cause inflammation. This can help you get better relief.
You should take ibuprofen exactly as prescribed by your doctor to treat your pain. Take it regularly for at least 3 days before or after you use it, as this can help reduce your risk of side effects.
If you are taking ibuprofen for pain, you should continue taking it for up to 4 days after you get your first dose of ibuprofen.
Ibuprofen is not for children under 18 years old.
NSAIDs may cause stomach or intestinal bleeding or other serious side effects.
If you have stomach or intestinal problems, stop taking ibuprofen and seek medical help right away.
If you are allergic to ibuprofen or any other ingredient in ibuprofen, you should avoid taking it.
You should avoid taking ibuprofen if you are over 65 years of age.
Ibuprofen may increase the risk of developing a stroke or heart attack or decrease your risk of these problems.
NSAIDs should not be taken within the first 12 hours of starting your period of pregnancy or within 2 days of your last dose of ibuprofen.
NSAIDs may also increase the risk of heart attack, heart failure, stroke, blood clots, and kidney problems.
If you have any of these conditions, you should talk to your doctor before taking ibuprofen. You should tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The authors have no relevant relationships to any other group.
BMI, Body Mass Index, Chronic Obstructive Pulmonary Disease, Ibuprofen,
The use of ibuprofen (Ibuprofen) for the treatment of acute pain in adults has been associated with a decrease in the incidence of the primary outcome measure used to measure the severity of acute pain and its duration, which may be associated with increased risk of fractures, infections, and cardiovascular events [
]. This study aimed to determine the effects of ibuprofen (IBU) therapy on fracture risk in adults and to investigate the associations between ibuprofen and fractures, infections, cardiovascular events, and other outcomes.
This observational cohort study was conducted between March 2006 and October 2008 in the general population of the European Region (France, Germany, Italy, Portugal, Spain, and Spain). Data were collected from the patients' medical records, and the incidence of fractures, infections, cardiovascular events, and other outcomes was recorded. All participants provided written informed consent prior to study inclusion in the study.
Data were collected by means of a detailed electronic medical records review and a medical questionnaire. The study was conducted in line with the French legislation and the guidelines on the use of medical records. The study population was patients who were diagnosed with chronic backache, acute interphalangeal or upper end of the spine pain in adult patients, as well as those with acute interphalangeal pain associated with fractures, infections, and other disorders, such as myelopathy or other chronic musculoskeletal diseases.
The study was conducted in accordance with the Good Clinical Practice guidelines on the use of medical records in acute pain [
All adults who had a history of chronic backache or acute interphalangeal pain in adult patients between March 2006 and October 2008 were included. Patients with backache had been diagnosed with chronic backache in the preceding year, as well as acute interphalangeal pain. Patients with acute interphalangeal pain were diagnosed with acute interphalangeal pain in the following year.
The patients who met the inclusion criteria were followed for 6 months. The authors sought to evaluate the incidence of fractures, infections, cardiovascular events, and other outcomes. The authors did not use the term "discharge" in the study. In addition, the authors did not use the terms "adverse events" or "adverse events" in the study to describe them.
All patients were recruited via the outpatient department of the University of Paris Hospitals, and were instructed to complete an online questionnaire, which was used by the patients for the first time, which included a medical history of chronic backache, acute interphalangeal or upper end of the spine pain, and a physical examination. The patients had their medical record and were asked to record their height, weight, and other relevant information. Patients who did not meet the inclusion criteria were asked to return their medical records to the authors for the next 6 months.
The primary outcome measures were incidence of fractures, infections, cardiovascular events, and other outcomes, respectively. In order to assess differences between ibuprofen and placebo, the primary outcomes were the incidence of fractures, infections, and cardiovascular events (heart attack, stroke, heart failure, MI, and death) for the ibuprofen group vs. ibuprofen plus placebo, respectively. For the ibuprofen group, a logistic regression analysis was performed to assess the associations between ibuprofen and fractures, infections, cardiovascular events, and other outcomes.
A logistic regression analysis was conducted to examine the association between ibuprofen and fractures, infections, cardiovascular events, and other outcomes. The analysis was performed by the inclusion criteria.
General Product Description
This medicine is for those who are suffering from pain, fever and inflammation. It should be used only under the guidance and prescription of a doctor, or a specialist, and the information is generalised about the mechanism of action.
It is a non-steroidal anti-inflammatory drug (NSAID).
Indication
It works by relieving pain and swelling. It also works to reduce inflammation.
Directions
Adults and children over 12 years: take 1 to 2 tablets (2 tablets in a 2-tablet pack) every 4 to 6 hours as needed. Swallow whole with a glass of water. Do not chew or crush.
Children under 12: Take 1 tablet with a glass of water every 4 to 6 hours, every 8 to 12 hours, every 12 hours, or every 24 hours. Do not take more than 1 tablet in 24 hours.
Diet: Take a tablet as it works to reduce pain and inflammation.
Warnings
Do not use it if you: have or have had stomach ulcers; are taking other NSAIDs (aspirin, ibuprofen, naproxen, or others); are allergic to aspirin or any of the ingredients in the product (such as ibuprofen or ibuprofen lactose); have had stomach ulcers or bleeding in the stomach (such as ulcers or bleeding in the stomach ulcers); have or have had stomach ulcers or bleeding in the stomach (such as ulcers or bleeding in the stomach ulcers); are pregnant or plan to become pregnant; are breast-feeding; are allergic to aspirin or any of the ingredients in the product (such as ibuprofen or ibuprofen lactose); have asthma or a history of asthma or other allergic disorders (such as hives, difficulty breathing, hayfever, allergic skin conditions, hives, swelling in the face or throat); have asthma or a history of asthma or other allergic disorders (such as hives, swelling in the face or throat); are taking oral corticosteroids (such as prednisone). To make sure you are safe for children under 12 years, it is important to consult a doctor before taking the medicine.
Read the enclosed leaflet carefully before starting treatmentImportant Information
Do not use:- If symptoms persist - If symptoms last or have lasted 24 hours - If symptoms last for more than 24 hours - If you have an allergic reaction, or have previously had an allergic reaction to the same or similar drug, e.g. hayfever, asthma, runny nose, itchy skin, blisters, rash, or peeling skin
If you are allergic to aspirin, or any of the other ingredients in the product.
Do not use:- If you are taking or have recently taken an MAOI (medicinal oestrogen) - If you have a history of breast cancer - If you have kidney disease
Do not use- if you are pregnant or trying to become pregnant. Do not use:- if you are breast-feeding or planning to breast-feed. Do not use:- if you are taking or have recently taken an MAOI (medicinal oestrogen) - If you have a history of breast cancer - If you have kidney disease
Read the enclosed leaflet before starting treatmentCaution
Please read the enclosed leaflet carefully before taking this medicine. It contains important information and possible side effects. If you have any questions, please speak to your doctor.
Read the enclosed leaflet carefully before taking this medicine. If you have any questions, ask your doctor.Take this medicine exactly as prescribed by your doctor. Do not exceed the recommended dose or use it for longer than recommended by your doctor.
The course of treatment may take up to 4 weeks from the date of treatment to the most effective one. The dose is decided by your doctor. Do not change your dose or treatment plan without your doctor's advice.
Do not take in larger or smaller amounts or for longer than recommended by your doctor.
The use of this medicine in children is not recommended. Therefore, treatment should only be done under the supervision of a doctor.
This medicine contains an NSAID (aspirin or ibuprofen) and is not recommended for use by children under 12 years of age.
Ibuprofen is a pain reliever that is used to treat mild to moderate pain in adults. When this medicine is taken by mouth, it is absorbed through the skin into the bloodstream. Ibuprofen passes through the body as an aerosol, is absorbed into the blood, and is eliminated from the body by the body.
If you are experiencing mild to moderate pain in your upper and lower back or muscle, you should not take ibuprofen, as it may cause serious side effects. Ibuprofen can cause side effects, so you should talk to your doctor or pharmacist if you experience any of these symptoms:
If you experience any of the following symptoms, stop taking the medicine and contact your doctor as soon as possible:
If you experience any of the following symptoms, stop taking the medicine and contact your doctor:
The most common side effects of ibuprofen are headache, stomach pain, nausea, or dizziness. If these side effects persist or become bothersome, call your doctor.
Stade de France Pharmacy